Kronos Bio Prices IPO At $19/Shr, Above Estimated Range

By RTTNews Staff Writer   ✉   | Published:

Kronos Bio, Inc. announced that it has priced initial public offering of 13.16 million shares of common stock at $19.00 per share. The offering is expected to close on October 14, 2020.

The company has originally filed to sell 10.29 million shares at a range of $16.00 and $18.00 per share.

Earlier on Thursday, the company filed an amendment and the size of the IPO was increased to 13.16 million shares.

The company expects offering gross proceeds, before expenses, to be about $250.00 million.

In addition, Kronos Bio has granted underwriters a 30-day option to buy additional 1.97 million common shares at the initial public offering price less the underwriting discounts and commissions.

The company shares are expected to begin trading on the Nasdaq Global Select Market on October 9, 2020, under the ticker symbol "KRON."

Goldman Sachs & Co. LLC, Jefferies, Cowen and Piper Sandler are acting as joint book-running managers for the offering.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Disney Splits Media And Entertainment Businesses To Accelerate DTC Strategy
Walt Disney Co. is reorganizing its media and entertainment businesses aiming to accelerate its direct-to-consumer or DTC strategy following the significant success of its streaming service Disney+. In a statement, the company stated that its media and entertainment businesses will be separated into creative engines, as well as Media and Entertainment Distribution Group.
J&J Pauses Late-stage COVID-19 Vaccine Trial On Unexplained Illness
Johnson & Johnson (JNJ) has paused the phase III study of its COVID-19 vaccine candidate, JNJ-78436735, due to an unexplained illness in a study participant, Stat News reported, citing a document sent to outside researchers running the 60,000-patient clinical trial.
Twitter Takes Additional Steps To Prevent Interference In US Election
Twitter has taken additional steps to prevent any manipulation or interference in the upcoming U.S. Elections or other civic processes through misleading Tweets. It announced significant product and enforcement updates to enable the smooth conduct of the democratic process. The social media platform has recently expanded its civic integrity policy to address misleading information.